Skip to main content
Entrada Therapeutics, Inc. logo

Entrada Therapeutics, Inc. — Investor Relations & Filings

Ticker · TRDA ISIN · US29384C1080 US Manufacturing
Filings indexed 422 across all filing types
Latest filing 2022-06-06 Director's Dealing
Country US United States of America
Listing US TRDA

About Entrada Therapeutics, Inc.

https://www.entradatx.com/

Entrada Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing a new class of medicines to treat devastating diseases. The company's proprietary Endosomal Escape Vehicle (EEV) platform is designed to enable the intracellular delivery of a wide range of therapeutics, allowing access to targets that have historically been considered undruggable. Entrada's development pipeline is concentrated on rare conditions, with programs targeting neuromuscular diseases, including Duchenne muscular dystrophy, as well as ocular diseases. The company's mission is to transform the lives of patients by establishing EEV-based therapeutics as a new treatment modality.

Recent filings

Filing Released Lang Actions
OWNERSHIP DOCUMENT
Director's Dealing
2022-06-06 English
OWNERSHIP DOCUMENT
Director's Dealing
2022-06-06 English
OWNERSHIP DOCUMENT
Director's Dealing
2022-06-06 English
FORM 8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated June 2, 2022, reporting on the results of the 2022 Annual Meeting of Stockholders of Entrada Therapeutics, Inc. It details the submission of matters to a vote of security holders, including election of directors and ratification of the independent auditor. The content focuses on voting results from the annual meeting, which aligns with the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document is not an annual report, earnings release, or proxy statement itself, but specifically reports the voting outcomes. The length and detail confirm it is not a brief announcement or a certification, but a full voting results report.
2022-06-03 English
FORM 4 SUBMISSION
Director's Dealing
2022-05-25 English
FORM 4 SUBMISSION
Director's Dealing
2022-05-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.